CD14+HLA-DRlow/ expression: A novel prognostic factor in chronic lymphocytic leukemia

E-ISSN： 1792-1082|9|3|1167-1172

ISSN： 1792-1074

Source： Oncology Letters, Vol.9, Iss.3, 2015-01, pp. : 1167-1172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD49d expression in chronic lymphocytic leukemia: a prognostic parameter and a therapeutic target

By Bulian Pietro Gaidano Gianluca Poeta Giovanni Del Gattei Valter

Future Oncology, Vol. 4, Iss. 3, 2008-06 ,pp. : 355-358

Future Medicine

Access to resources Recommend Favorite

Prognostic and Predictive Indicators in Chronic Lymphocytic Leukemia(

International Journal of Cancer Research and Prevention, Vol. , Iss. , 2017-01 ,pp. : 101-127

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

CD24 Expression Is a Novel Prognostic Factor in Esophageal Squamous Cell Carcinoma

By Sano Akihiko

Annals of Surgical Oncology, Vol. 16, Iss. 2, 2009-02 ,pp. : 506-514

Springer Publishing Company

Access to resources Recommend Favorite

Circulating classical CD14++CD16- monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163

Oncology Reports, Vol. 34, Iss. 3, 2015-01 ,pp. : 1269-1278

Spandidos Publications

Access to resources Recommend Favorite

Alemtuzumab in chronic lymphocytic leukemia

By James Danelle F Kipps Thomas J

Future Oncology, Vol. 3, Iss. 1, 2007-02 ,pp. : 29-42

Future Medicine

Access to resources Recommend Favorite